KMCSHIL

KMC Speciality Hospitals India share price & financials

Price
₹115.1
Market cap
₹2.3k Cr
Sector
Healthcare

Quarterly results

Q1 FY27: revenue up 37.3%, net profit up 112.5% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue56 61 61 67 75 +34%82 +34%82 +34%92 +37%
EBITDA13 16 15 16 21 +62%25 +56%26 +73%28 +75%
Net profit4 8 5 8 11 +175%14 +75%15 +200%17 +113%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance +110.0% 1Y

₹60₹80₹100₹120₹140Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Aug 26

1Y: ₹65.95 on 10 Sept 2025 → ₹138.47. High ₹141.65 (21 Aug 2026), low ₹65.95 (10 Sept 2025).

Financials, as filed

Revenue grew 31.5% a year over 2 years, FY24 to FY26. Operating margin widened to 28.8%.

Year endingFY24FY25FY26
Revenue₹177 Cr₹231 Cr₹306 Cr
Operating profit₹47 Cr₹57 Cr₹88 Cr
Operating margin26.6%24.7%28.8%
Interest₹0 Cr₹9 Cr₹8 Cr
Depreciation₹9 Cr₹19 Cr₹21 Cr
Net profit₹30 Cr₹23 Cr₹48 Cr
Net margin16.9%10.0%15.7%
Cash from operations₹38 Cr₹58 Cr₹79 Cr
Free cash flow₹-37 Cr₹-6 Cr₹63 Cr
ROCE22.0%17.0%26.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr₹16 Cr
Reserves₹47 Cr₹70 Cr₹97 Cr₹127 Cr₹166 Cr₹194 Cr
Borrowings₹29 Cr₹29 Cr₹50 Cr₹82 Cr₹86 Cr₹84 Cr
Other liabilities₹13 Cr₹13 Cr₹18 Cr₹38 Cr₹31 Cr₹38 Cr
Total liabilities₹105 Cr₹129 Cr₹182 Cr₹264 Cr₹300 Cr₹332 Cr
Fixed assets₹74 Cr₹75 Cr₹84 Cr₹206 Cr₹245 Cr₹248 Cr
Capital work in progress₹2 Cr₹6 Cr₹34 Cr₹1 Cr₹0 Cr₹0 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other assets₹29 Cr₹48 Cr₹63 Cr₹57 Cr₹55 Cr₹84 Cr
Total assets₹105 Cr₹129 Cr₹182 Cr₹264 Cr₹300 Cr₹332 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

The ownership split has held steady since Jun 2025. The shareholder count grew 1% to 88,487.

Promoters
75.0%
FIIs
0.0%
Public
25.0%

Since Jun 2025

  • FIIs +0.02 pp
  • Public −0.02 pp
  • Promoters 0.00 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 75.0%, Public 25.0%.Dec '23: Promoters 75.0%, Public 25.0%.Mar '24: Promoters 75.0%, Public 25.0%.Jun '24: Promoters 75.0%, Public 25.0%.Sep '24: Promoters 75.0%, Public 25.0%.Dec '24: Promoters 75.0%, Public 25.0%.Mar '25: Promoters 75.0%, FIIs 0.0%, Public 25.0%.Jun '25: Promoters 75.0%, Public 25.0%.Sep '25: Promoters 75.0%, Public 25.0%.Dec '25: Promoters 75.0%, Public 25.0%.Mar '26: Promoters 75.0%, Public 25.0%.Jun '26: Promoters 75.0%, FIIs 0.0%, Public 25.0%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of KMC Speciality Hospitals India Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Sri Kauvery Medical Care (India) Limited 75.00%newly disclosed
D Chitra 1.36%unchanged
Anitha S 1.13%unchanged
Tn Apex Skill Development Centre For Healthcare 0.00%newly disclosed
Yashomati Hospitals Private Limited 0.00%newly disclosed
Curtis Drug Point Private Limited 0.00%newly disclosed
Healthcare Capital Private Limited 0.00%newly disclosed
Sri Kauvery Medical Care (India)Limited off the list

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

What the price assumes

Fair

To justify its price of ₹138, this stock must grow earnings at 26% every year for 7 years. Our analysis caps realistic growth at ~24%. At that growth it is worth ₹126 — downside of 9%.

Growth the price implies
25.9% a year
for 7 years, fading to 4%
It has actually compounded at
26.5% a year
net profit, FY24–FY26 · EPS 24.0%
The gap
0.0 pp
-9% downside if it only repeats history
Price today ₹138.47 Value at the reference growth ₹125.71

Change the assumptions yourself →